Page last updated: 2024-11-03

riluzole and Dysphagia

riluzole has been researched along with Dysphagia in 7 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"Treatment with riluzole improves survival but has a marginal effect on the rate of functional deterioration, whereas non-invasive ventilation prolongs survival and improves or maintains quality of life."2.44Clinical care of patients with amyotrophic lateral sclerosis. ( Leigh, PN; Mitsumoto, H; Radunović, A, 2007)
"In a proportion of familial amyotrophic lateral sclerosis there is a mutation in the gene encoding the enzyme copper/zinc superoxide dismutase 1; this has allowed mutation screening and generated considerable laboratory based research."2.41Management of motor neurone disease. ( Howard, RS; Orrell, RW, 2002)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Romero-Gangonells, E1
Virgili-Casas, MN1
Povedano, M1
Barceló, MA1
Nagashima, K1
Furuta, N1
Makioka, K1
Fujita, Y1
Ikeda, M1
Ikeda, Y1
Kraft, P1
Beck, M1
Grimm, A1
Wessig, C1
Reiners, K1
Toyka, KV1
Zoing, M1
Kiernan, M1
Howard, RS1
Orrell, RW1
Forbes, RB1
Colville, S1
Swingler, RJ1
Radunović, A1
Mitsumoto, H1
Leigh, PN1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Initiation of Long-term Home Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode During a Daytime Trial[NCT01746381]30 participants (Actual)Interventional2014-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for riluzole and Dysphagia

ArticleYear
Management of motor neurone disease.
    Postgraduate medical journal, 2002, Volume: 78, Issue:926

    Topics: Deglutition Disorders; Humans; Motor Neuron Disease; Neuroprotective Agents; Palliative Care; Respir

2002
Clinical care of patients with amyotrophic lateral sclerosis.
    The Lancet. Neurology, 2007, Volume: 6, Issue:10

    Topics: Amyotrophic Lateral Sclerosis; Deglutition Disorders; Disease Progression; Humans; Neuroprotective A

2007

Other Studies

5 other studies available for riluzole and Dysphagia

ArticleYear
Clinical and demographical characteristics in a cohort of MND patients treated with riluzole. Differences between tablets and oral suspension.
    Amyotrophic lateral sclerosis & frontotemporal degeneration, 2023, Volume: 24, Issue:5-6

    Topics: Amyotrophic Lateral Sclerosis; Deglutition Disorders; Female; Humans; Male; Neuroprotective Agents;

2023
An analysis of prognostic factors after percutaneous endoscopic gastrostomy placement in Japanese patients with amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 2017, May-15, Volume: 376

    Topics: Aged; Amyotrophic Lateral Sclerosis; Carbon Dioxide; Deglutition Disorders; Enteral Nutrition; Excit

2017
[Amyotrophic lateral sclerosis: management of bulbar symptoms].
    Der Nervenarzt, 2010, Volume: 81, Issue:10

    Topics: Affective Symptoms; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Combined Modality Therapy;

2010
Motor neurone disease - caring for the patient in general practice.
    Australian family physician, 2011, Volume: 40, Issue:12

    Topics: Australia; Deglutition Disorders; Disease Progression; Electrophysiology; General Practice; Humans;

2011
Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.
    Journal of neurology, 2004, Volume: 251, Issue:7

    Topics: Aged; Amyotrophic Lateral Sclerosis; Brain Stem; Deglutition Disorders; Enteral Nutrition; Female; G

2004
chemdatabank.com